Literature DB >> 30840065

Why Do Normal Children Have Acromegalic Levels of IGF-I During Puberty?

Anders Juul1,2, Niels E Skakkebæk1,2.   

Abstract

CONTEXT: The rapid pubertal height growth is unique to humans, but why do we have it? Although the spurt contributes 13% to 15% to the final adult height, we hypothesized that the biological significance of the high acromegalic levels of GH and IGF-I, which are behind the pubertal growth spurt, might primarily occur to stimulate the reproductive organs. EVIDENCE SYNTHESIS: Animal data have demonstrated that adult Igf1 and Igf2 gene knockout mice that survive show a dramatic reduction in the size of the reproductive organs and are infertile. In humans, case reports of mutations in the genes affecting the GH-IGF axis and growth (GH, GHRH, GH-R, STAT5b, IGF-I, IGF-II, IGF-1R, PAPPA2) are also characterized by delayed pubertal onset and micropenis. Furthermore, GH treatment will tend to normalize the penile size in patients with GH deficiency. Thus, the endocrine effects of high IGF-I levels might be needed for the transition of the sexual organs, including the secondary sex characteristics, from the "dormant" stages of childhood into fully functioning reproductive systems. The peak IGF-I levels, on average, occur 2 years after the peak height growth velocity, suggesting reasons other than longitudinal growth for the high IGF-I levels, and remain high in the years after the height spurt, when the reproductive systems become fully functional.
CONCLUSION: We suggest that the serum levels of IGF-I should be monitored in children with poor development of sexual organs, although it remains to be investigated whether GH should be added to sex steroids in the management of hypogonadism for some pubertal children (e.g., boys with micropenis).
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30840065     DOI: 10.1210/jc.2018-02099

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Anti-Müllerian Hormone, Growth Hormone, and Insulin-Like Growth Factor 1 Modulate the Migratory and Secretory Patterns of GnRH Neurons.

Authors:  Rossella Cannarella; Alyssa J J Paganoni; Stefania Cicolari; Roberto Oleari; Rosita A Condorelli; Sandro La Vignera; Anna Cariboni; Aldo E Calogero; Paolo Magni
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

2.  Testicular Growth and Pubertal Onset in GH-Deficient Children Treated With Growth Hormone: A Retrospective Study.

Authors:  Rossella Cannarella; Manuela Caruso; Andrea Crafa; Tiziana Antonia Timpanaro; Manuela Lo Bianco; Santiago Presti; Rosita A Condorelli; Sandro La Vignera; Aldo E Calogero
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-02       Impact factor: 5.555

3.  Development of male-larger sexual size dimorphism in a lizard: IGF1 peak long after sexual maturity overlaps with pronounced growth in males.

Authors:  Brandon Meter; Lukáš Kratochvíl; Lukáš Kubička; Zuzana Starostová
Journal:  Front Physiol       Date:  2022-08-10       Impact factor: 4.755

4.  CENTRAL PRECOCIOUS PUBERTY IN TWO BOYS WITH PRADER-WILLI SYNDROME ON GROWTH HORMONE TREATMENT.

Authors:  Elena Monai; Anders Johansen; Erik Clasen-Linde; Ewa Rajpert-De Meyts; Niels Erik Skakkebæk; Katharina M Main; Anne Jørgensen; Rikke Beck Jensen
Journal:  AACE Clin Case Rep       Date:  2019-08-15

5.  Pubarche and Gonadarche Onset and Progression Are Differently Associated With Birth Weight and Infancy Growth Patterns.

Authors:  Christine Wohlfahrt-Veje; Jeanette Tinggaard; Anders Juul; Jorma Toppari; Niels E Skakkebæk; Katharina M Main
Journal:  J Endocr Soc       Date:  2021-06-10

6.  Role of the GH-IGF1 axis on the hypothalamus-pituitary-testicular axis function: lessons from Laron syndrome.

Authors:  Rossella Cannarella; Andrea Crafa; Sandro La Vignera; Rosita A Condorelli; Aldo E Calogero
Journal:  Endocr Connect       Date:  2021-08-25       Impact factor: 3.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.